Tatva Chintan Tumbles After Reporting Sequential Decline

Shares of Tatva Chintan Pharma Chem Ltd. fell nearly 9.5%, the steepest intraday decline since its listing on July 29, 2021.

• The company reported a sequential decline in net profit and revenue in its December quarter earnings, post market hours on Monday.
• All the four analysts tracking the company maintained ‘buy’ recommendations. The overall consensus price of analysts tracked by Bloomberg implied an upside of 4.4%.
• Trading volume on the stock was above 15 times the 30-day average volume at this time of the day.

Source: Exchange Filing, Bloomberg

सोशल मीडिया अपडेट्स के लिए हमें
Facebook ( https://www.facebook.com/goldsilverreports/ )
linkedin (https://www.linkedin.com/in/nealbhai/ )
 और Twitter ( https://twitter.com/goldsilverrepor ) पर फॉलो करें।

हमारी फ्री सर्विस और लोगो की paid सर्विस से कई गुना अच्छी है।
आपको हर दिन दिए जाएंगे 3 से 5 कॉल बिलकुल फ्री
हर CALL में PROFIT दिये जायेंगे
तो जल्दी से MCX CHANNEL को JOIN कर लो (NEAL BHAI REPORTS)
JOIN US CLICK HERE

EQUITY CHANNEL को JOIN कर लो (EQUITY FREE TIPS)
JOIN US CLICK HERE